Home›Stock Screener›Indrayani Biotech

Indrayani Biotech Share Price Today | Stock Price & Indrayani Biotech Share Screener

INDRANIB Agricultural Products
Live Share Price BSE
₹10.08
▲ 0.45 (4.67%)
2026-10-05 00:00:00

As of October 5, 2026, the live Indrayani Biotech share price (BSE: INDRANIB) is ₹10.08, up 4.67% from the previous close, with shares trading between ₹9.15 and ₹10.11 in today's trading session, and a 52-week range of ₹6.90–₹15.94. Check INDRANIB annual price range for the annual price range and momentum. Use the Indrayani Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Indrayani Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹39 and net income of ₹1, with EBITDA of ₹3, an operating margin of 6.0% and a profit margin of 2.6%.

Indrayani Biotech Market Cap ₹75.20 Cr.
INDRANIB P/E Ratio (TTM) 34.39
Indrayani Biotech P/B Ratio 0.62
EPS (TTM) ₹0.48
Dividend Yield -
Debt to Equity 1.79
INDRANIB 52 Week High ₹15.94
Indrayani Biotech 52 Week Low ₹6.90
Operating Margin 6.00%
Profit Margin 2.56%
INDRANIB Revenue (TTM) ₹39.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹253.00
Total Equity ₹73.00

Indrayani Biotech Share Price Chart

Track the current stock price of Indrayani Biotech with an interactive chart. Analyse INDRANIB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Indrayani Biotech stock quote in one place.

The quote of ₹10.08 sits between the 52-week low of ₹6.90 and the 52-week high of ₹15.94, and the latest session moved 4.67% from the previous close.

Indrayani Biotech Company Profile - Fundamental Screener

Screen Indrayani Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDRANIB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the FMCG sector and the Agricultural Products industry, and it trades under ISIN INE007C01021.

Company Details

Classification

Sector FMCG
Industry Agricultural Products
Sub-Sector Agricultural Products
Segment E

Identifiers and Leadership

ISIN INE007C01021

Indrayani Biotech Balance Sheet Screener

Screen INDRANIB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹253, down from ₹268 in 2025.

Latest statistics put total assets at ₹253 and shareholder funds at ₹73, with a leverage ratio of 1.79.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 253 268 234 156 51 40 52
Current Assets 159 178 145 78 19 9 19
Fixed Assets 64 58 62 58 17 15 17

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 58 66 71 36 7 8 7
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 73 100 76 48 25 20 31
Share Capital 46 46 46 44 34 34 4
Reserves & Surplus 27 24 18 10 -10 -15 -3

Indrayani Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Indrayani Biotech income statement and profit fundamentals. Analyze INDRANIB quarterly results. Indrayani Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹39 and net profit was ₹1, equal to earnings per unit of ₹0.24, at an operating margin of 6%.

In that period expenses were ₹36, interest cost ₹3 and tax ₹-2. The next period listed, 2025-Mar, shows revenue of ₹53 and net profit of ₹-9.

Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun

Revenue and Expenses

Revenue 39 53 30 38 36 45 32 31 17 51 42 41 39 17 26
Expenses 36 56 27 34 32 34 26 26 14 46 40 33 36 15 23

Operating Costs and Margins

EBITDA 3 -3 3 4 4 11 6 5 3 5 3 7 4 2 3
Operating Profit % 6.00% -11.00% 7.00% 7.00% 8.00% 23.00% 19.00% 17.00% 17.00% 6.00% 6.00% 18.00% 9.00% 13.00% 12.00%
Depreciation 1 -2 1 1 1 1 4 3 2 1 1 1 1 0 1
Interest 3 7 2 2 3 6 1 1 1 2 2 1 1 0 1

Profit and Earnings

Profit Before Tax -1 -8 0 1 0 5 1 1 0 2 0 6 1 2 2
Tax -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 -9 0 1 0 5 1 1 0 1 0 6 1 2 2
EPS 0.24 -1.88 0.03 0.09 0.03 0.58 0.10 0.13 0.05 0.32 -0.06 0.89 0.22 0.47 0.52

Indrayani Biotech Cash Flow Screener - Liquidity Fundamentals

Screen INDRANIB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities used ₹7.

Over the same period, investing activities provided ₹25 and financing activities used ₹18.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities -7 -30 16 4 0 6
Investing Activities 25 -16 -47 -1 -1 -4

Financing and Net Cash

Financing Activities -18 44 33 -3 0 -1
Net Cash Flow 0 -3 2 1 -1 1

Indrayani Biotech Shareholding Pattern Screener

See Indrayani Biotech shareholding pattern with promoter, FII, and DII holdings. Check Indrayani Biotech promoter holding and ownership changes for INDRANIB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 33.26%, foreign institutions 0.00%, domestic institutions 3.13% and the public 48.99%, spread across 25,509 shareholders.

The shareholder count was 25,509 in 2026-Mar, compared with 25,811 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Apr

Promoter Holding

Promoter Holding 33.26% 32.92% 33.28% 33.28% 33.26% 33.26% 42.13% 33.57%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 3.13% 3.13% 3.66% 3.11% 3.13% 3.13% 8.47% 6.75%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 48.99% 49.48% 46.64% 47.32% 48.08% 48.44% 44.33% 55.78%
Other Holding 14.62% 14.47% 16.42% 16.29% 15.53% 15.17% 5.07% 3.90%
Shareholder Count 25,509 25,811 25,126 25,704 25,686 25,565 23,914 23,958

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Indrayani Biotech. Indrayani Biotech dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Indrayani Biotech.

Indrayani Biotech Stock Index Membership - Nifty & Sensex

See which indices include Indrayani Biotech stock. Check INDRANIB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Indrayani Biotech is not part of any tracked indices.
Only major market indices are tracked in our system.

Indrayani Biotech Market Events Screener - Corporate Actions

Get Indrayani Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Indrayani Biotech stock events that may affect INDRANIB share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 7, 2026, with a record date of October 7, 2026.

It is followed by Quarterly Result Announcement dated August 17, 2026 and Rights dated April 28, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-07 2026-10-07 Quarterly Result Announcement NA -7.05%
2026-08-17 2026-08-17 Quarterly Result Announcement NA -0.38%
2026-04-28 2026-04-28 Rights 5:7 2.53%
2026-02-26 2026-02-26 Quarterly Result Announcement NA -5.57%
2025-12-11 2025-12-11 Quarterly Result Announcement NA -0.39%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -2.00%
2025-09-29 2025-09-29 Annual General Meeting NA 9.85%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -5.08%
2025-06-13 2025-06-13 Quarterly Result Announcement NA -6.73%
2025-02-27 2025-02-27 Quarterly Result Announcement NA -19.82%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -6.60%
2024-08-22 2024-08-22 Annual General Meeting NA -10.28%

Indrayani Biotech Competitors Screener - Peer Stocks Comparison

Screen INDRANIB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
LT Foods 13,869 21.61 11,023 25.69% 625 35.15
KRBL 8,570 11.33 6,168 9.07% 648 36.77
Gujarat Ambuja Exports 7,216 17.46 5,836 24.30% 304 42.14
Trualt Bioenergy 3,812 23.91 1,814 -7.85% 97 52.86
Kaveri Seed Company 3,670 14.81 1,424 13.81% 296 43.27
Amir Chand Jagdish Kumar (Exports) 2,145 17.42 2,287 14.13% 103 60.91
Sanstar 2,047 59.85 785 -27.46% 35 34.23
GRM Overseas 1,596 21.11 1,806 31.41% 76 32.17
Chaman Lal Setia Exports 1,416 11.22 1,450 -3.56% 115 41.19
Avt Natural Products 1,324 15.98 727 27.04% 65 49.10

Indrayani Biotech Company Announcements - News & Reports Screener

Screen INDRANIB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated October 2, 2026 and October 1, 2026.

Date Update Actions
2026-10-02 Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015 -
2026-10-02 Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October 2026 -
2026-10-01 Closure of Trading Window -
2026-09-15 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-09 Letter Of Offer For Rights Issue -
2026-09-09 Corporate Action-Outcome of Right issue -
2026-09-09 Appointment of Company Secretary and Compliance Officer -
2026-09-07 Resignation Of Secretarial Auditor. -
2026-09-07 Extension Of Time Granted For Holding The AGM For FY 2025-26 -
2026-08-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-19 Result-Audited Financial Results For Quarter And Year Ended March 31 2026 Along With Report Of Statutory Auditor. -
2026-08-17 Board Meeting Outcome for Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31St March 2026 Along With Report Of Statutory Auditors. -
2026-08-17 Results-Delay in Financial Results -
2026-08-12 Board Meeting Intimation for Board Meeting Intimation For Intimation For Board Meeting To Be Held On 17Th August 2026 -
2026-07-16 Announcement Under Regulation 30 (LODR)-GST Revocation Order -
2026-07-15 Announcement Under Regulation 30 (LODR) Updates-IT Order -
2026-07-15 IT Order -
2026-07-06 Compliance Certificate Under Reg 74(5) Of SEBI (DP) Reg 2018. -
2026-06-27 Closure of Trading Window -
2026-06-22 Outcome Of The Rights Issue Committee Meeting Held On 22Nd June 2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹10.08, within a 52-week range of ₹6.90 to ₹15.94. The P/E ratio is 34.39 and the P/B ratio is 0.62, with earnings per unit of ₹0.48. Market capitalisation stands at ₹75.20 Cr. The company operates in the FMCG sector, in the Agricultural Products industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 15 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.